Resources & Guides

Advocacy tools, downloads, and lived experience — all in one place.

magnifying glass icon
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News Articles

01
Effects of antidepressants on physical health ranked for first time
02
‘Girl, Take Your Crazy Pills!’ Antidepressants Recast as a Hot Lifestyle Accessory Influencers tout the drugs, but many unsuspecting followers find the side effects take the fun out of life
03
Quitting antidepressants can lead to these surprising and lingering symptoms, according to experts
04
FDA Adverse Event Data Reveals Disturbing Links Between SSRIs And Violent Behavior
05
A generation of women over 50 stuck taking antidepressants
06
The dangerous side of popular sleep and anxiety drugs like Xanax and Lorazepam
07
When They Couldn’t Get Benzos Anymore, Quitting Was Torture
08
Generation Xanax: The Dark Side of America’s Wonder Drug
09
Medication warning after Thomas Kingston's death
11
The new science ending the ‘terror and panic’ of coming off long-term antidepressant use
12
Coroner issues warning about antidepressants after suicide of royal’s husband
13
These medications could give you dementia if you take them too often — two are over-the-counter
14
DOCTOR WARNING The 5 common drugs that could ‘raise your risk of dementia’ – including hay fever, indigestion and anxiety meds
14
Antidepressant withdrawal: The hidden danger
16
We asked readers about taking antidepressants. The response points to a ‘silent epidemic’ and urgent need for reform
18
What patients — and doctors — should know about ‘benzo’ withdrawal
19
Benzo nightmare: US doctor on a personal mission to highlight the dangers of the drug
20
Inside CNN Benzos Report: The Next Big Drug Crisis?
22
An epidemic — and it’s not opioids
24
With benzos, a doctor discovers ease of dependency, ordeal of withdrawal
24
I Tried to Get Off Ativan

Tapering Guides & Tool Kits

The Maudsley Deprescribing Guidelines
Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs
The Ashton Manual
Benzodiazepines: How They Work and How to Withdraw. Credit: Benzodiazepine Information Coalition
ASAM: The JOINT CLINICAL PRACTICE GUIDELINE ON
Benzodiazepine Tapering: Consideratons when Benzodiazepine Risks Outweigh Benefits
Benzodiazepine & Antidepressant Withdrawal & Protracted Withdrawal SYMPTOM LIST
Extensive list of symptoms linked to benzodiazepine & antidepressants
Antidepressant withdrawal: understanding and supporting people across the continuum of care
CATAG Practice Tool
Benzodiazepine Tapering
Strategies and Solutions by BIC
the BENZODIAZEPINE TOOLKIT By Reconnexion
Harm Reduction Guide to Coming Off Psychiatric Drugs
Published by The Icarus Project & Freedom Center
As Prescribed Toolkit
A detailed guide to the benzodiazepine harm crisis, uniting science, clinical insight, and lived experience from As Prescribed
Stopping antidepressants by RC PYSHC Royal College of Psychiatrists.
*This guide may taper too quickly or broadly, missing some symptoms and late effects, but it notes hyperbolic tapering, liquid methods, and remains useful.
BENZODIAZEPINE DEPRESCRIBING GUIDANCE
Colorado Consortium for Prescription Drug Abuse Prevention

Support Groups and Forums

Benzo Warrior Community
benzodiazepine taper education & peer support
Surviving Antidepressants
tapering guidance & harm-reduction forum
BenzoBuddies
This forum may be triggering—consider asking a trusted person to help you find what you need
large benzo withdrawal forum; unfiltered stories
Antidepressant Facebook Support Group
SSRI withdrawal tips & community
Mirtazapine: Peer Support, Withdrawal, Recovery
mirtazapine-specific taper/repair group
Lexapro: Support, Withdrawal, Recovery
escitalopram-focused support & tapering
Benzodiazepine Recovery Reddit
Reddit peer recovery discussions
Cymbalta Hurts Worse (Duloxetine)
duloxetine tapering & bead-counting help
Marriages Destroyed by Antidepressants (Facebook)
relationship impacts & caregiver support
Fluoroquinolone Toxicity 24/7 Live Chat Group
round-the-clock FQ injury chat
Healing Floxing from Fluoroquinolones
recovery strategies for “floxed” members
FloxieHope
fluoroquinolone injury stories & resources
Akathisia Alliance for Education and Research
Nonprofit organization run by people who have experienced it.
Living with Akathisia
Support for anyone living with Akathisia. Akathisia is a state of agitation, distress, and restlessness caused from a side effect of medication.
The PSSD Subreddit
The PSSD subreddit is the largest, most active PSSD forum (17,000+ members).
PSSD Forum
A forum dedicated to collaborative research into PSSD (Post-SSRI Sexual Dysfunction).

Coalition & Resources

01
Benzo Information Coalition
Nonprofit educating about the potential adverse effects of benzodiazepines taken as prescribed.
02
The Alliance for Benzodiazepine Best Practices
We help individuals get the help they need, and we help prescribers offer better practices.
03
The Inner compass
Inner Compass Initiative (ICI) is a nonprofit offering education, resources, and peer support to help people make informed choices and heal beyond the limits of psychiatry.
04
Antidepressant Coalition for Education
We lead efforts to educate the public, advocate for change, and support research on the risks and long-term effects of antidepressant medications.
05
Colorado Consortium for Prescription Drug Abuse Prevention
The Benzodiazepine Action Work Group supports benzodiazepine safety through education, patient support, and informed prescribing practices.
06
PSSD NETWORK
A subset of people experience a debilitating condition known as Post-SSRI Sexual Dysfunction (PSSD) following the use of SSRIs, SNRIs and other SRI medications.
07
RxISK
RxISK is a free, independent drug safety website to help you weigh the benefits of any medication against its potential dangers.
08
This is Floxed
This site will provide you with the tools and information you need on your healing journey. The goal is to supply you with all the knowledge you need.
09
Psychotropic Deprescribing Council
The Council advances safe, research‑based deprescribing of psychiatric medications—through education, collaboration, and best clinical practices—to reduce harm and improve outcomes.
10
International Institute for Psychiatric Drug Withdrawal
The International Institute for Psychiatric Drug Withdrawal aims to develop ways to help people withdraw from psychiatric drugs.
11
Health Without Antidepressants
We have guided tens of thousands through a hyperbolic Cymbalta/duloxetine “Gradual Taper” to minimize withdrawal side effects.
12
Akathisia Alliance
A nonprofit led by people with lived akathisia experience—including clinicians and researchers—united to prevent harm through awareness and education.
13
Council of Australian Therapeutic Advisory Groups (CATAG)
CATAG is a national network of therapeutic advisory groups in Australia that provides consensus-based guidance to improve medicine use in hospitals.

Downloadable Letters

Research & Studies

01
Benzodiazepine Withdrawal Symptom Clusters: Distinct Phenotypes with Treatment Implications. (medRxiv preprint, 2025)
Identifies three main benzodiazepine withdrawal phenotypes — CRH-heavy, excitatory-neuroinflammatory, and autonomic — covering nearly 80% of patients, suggesting structured, biologically grounded patterns. Madhava, V.
04
Examining the Long-Term Impacts of Psychotropic Drugs and Considerations for People Discontinuing Treatment.
Timothy Wand, RN, NP, Mn(Hons), PhD. 2025
04
Perinatal SSRI exposure impacts innate fear circuit activation and behavior in mice and humans.
Giulia Zanni, Milenna T. van Dijk, Martha Caffrey Cagliostro, et al. 2025
05
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review.
Mi-Mi Zhang, Xuan Tan, Yong-Bo Zheng, et al. 2025
06
Antidepressants withdrawal effects and duration of use: a survey of patients enrolled in primary care psychotherapy services.
Mark A. Horowitz, Joshua E. J. Buckman, Rob Saunders, Elisa Aguirre, James Davies, Joanna Moncrieff. 2025
08
The nature and impact of antidepressant withdrawal symptoms and proposal of the Discriminatory Antidepressant Withdrawal Symptoms Scale (DAWSS).
Joanna Moncrieff, John Read, Mark A. Horowitz. 2024
09
Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey.
Alexis D. Ritvo, D. E. Foster, Christy Huff, A. J. Reid Finlayson, Bernard Silvernail, Peter R. Martin. 2023
10
A real-world pharmacovigilance study of lorazepam based on the FDA adverse event reporting system database.
Chunyue Fang, Xiaoyan Xu, Jianyi Li, Yuanyuan Zhong, Wei Dai, Jin Wen, Qionghui Yang, Ruixiang Chen. 2025
11
Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents.
George T. Kannarkat, Stanley N. Caroff, James F. Morley. 2022
12
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey.
Many report severe, debilitating, prolonged withdrawal beyond “7 days.” Alistair J. Reid Finlayson, Jane Macoubrie, Christy Huff, D. E. Foster, Peter R. Martin. 2022
12
Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.
69 reports; durations 5–166 months; affective and somatic symptoms common. Michael P. Hengartner, Lukas Schulthess, Anders Sorensen, Adele Framer. 2020
13
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?
James Davies, John Read. 2019
14
Tapering of SSRI treatment to mitigate withdrawal symptoms.
Mark A. Horowitz, David Taylor. 2019
15
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?
James Davies, John Read. 2019
16
“How many of 1,829 antidepressant users report withdrawal symptoms or addiction?”
Read, Cartwright & Gibson – 2018
17
Lader – “Benzodiazepines revisited—will we ever learn?”
Review on harms including persistent withdrawal phenomena and management cautions. 2011
18
“Prospective study of tardive dyskinesia in the elderly: rates and risk factors.” Woerner, Alvir, Saltz, Lieberman & Kane – (Antipsychotics)
Large prospective cohort showing TD incidence of 25%, 34%, and 53% after 1, 2, and 3 years. 1988
19
Jeste et al., Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.
(Neuroleptic-induced tardive dyskinesia). Cumulative incidence of TD reached 26% after 1 year, 52% after 2 years, and 60% after 3 years of neuroleptic treatment; 1995
19
Rickels et al. – Long-term therapeutic use & discontinuation.
Predictors and severity of withdrawal; outcomes after stopping. 1990
20
Ashton – “Protracted withdrawal syndromes from benzodiazepines.”
Classic paper describing symptoms lasting many months post-cessation. 1991
22
Ben-Sheetrit, J., et al. – “Post-SSRI sexual dysfunction: clinical features and preliminary diagnostic criteria.” (Annals of General Psychiatry)
Highlights that persistence of symptoms after discontinuation is central to the definition of PSSD. 2023
23
Healy, D., et al. – “Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors, and isotretinoin: 300 cases.” (International Journal of Risk & Safety in Medicine)
Case series documenting 300 reports of persistent sexual dysfunction linked to antidepressants, finasteride, and isotretinoin. 2018

Relevant Lawsuits

01
Successful Malpractice Lawsuit for Benzodiazepine
Dr. Josef / TaperClinic
02
She Sued Her Doctor for Benzo Harm — And Won
The Face Of MALpractice
03
An Interview with Attorney John Polivick
Benzodiazepine Information Coalition
4
To Sue or Not to Sue: An Interview with Attorney Michael Mosher
Benzodiazepine Awareness with Geraldine Burns
Looking for something else?

You might find what you need in the Resource Library or by receiving 1:1 Guidance from Malissa